CuraBase to be Presented at the AACR-NCI-EORTC Molecular Targets and Cancer Therpeutics Conference in Boston
Summary
This relational database is a novel tool to enhance analysis, communication, and collaboration on drug development projects in academia and industry.The company provides access to scientists involved in cancer and stem cell research who provide expert opinion and strategic advice on database development, development of drugs and diagnostics, target identification and validation, and promising research directions.### Mill Valley, CA, November 14, 2009 --( PR.com )-- Targeted Therapeutics Consulting, Inc. announced today that its lead product, the cancer drug development database CuraBase®, will be introduced to the scientific community at the AACR-NCI-EORTC Molecular Targets and Cancer Therpeutics Conference in Boston on Monday, November 16.Dr. W. Michael Korn, Associate Professor at the University of California San Francisco, will present a poster entitled “CuraBase: An Integrated Relational Database and Online Collaboration Platform for Cancer Drug Development.” The poster will be made available on the Company’s website www.targetedtherapeutics.com.About CuraBase®CuraBase® is a novel database and online collaboration tool ( www.curabase.com ) for professionals involved with cancer drug development in industry and academia.It was created in response to the extraordinary increase in the number of novel, targeted agents for the treatment of cancer has resulted in the generation of a vast amount of clinical and preclinical data at an ever-quickening pace.
Classifications
AskAI Classifications
LabelsLinked Companies
